MAM
PLRX icon

Monaco Asset Management’s Pliant Therapeutics PLRX Stock Holding History

Monaco Asset Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.44M Hold
1,938,747
– – 0.45% 37
2025
Q4 		$2.37M Buy
1,938,747
+1,116,054
+136% +$1.68M 0.41% 47
2025
Q3 		$1.22M Buy
822,693
+120,300
+17% +$184K 0.07% 60
2025
Q2 		$815K Buy
+702,393
New +$992K 0.14% 73

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Monaco Asset Management's PLRX Position: Q1 2026 in Review

Monaco Asset Management held its Pliant Therapeutics (PLRX) position steady in Q1 2026 at 1,938,747 shares worth $2.44M. The position accounts for 0.45% of the portfolio, ranked #37.

Monaco Asset Management first reported a position in PLRX in Q2 2025 and has held it in 4 quarters since. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Monaco Asset Management held 1,938,747 shares of Pliant Therapeutics worth $2.44M as of Q1 2026.
  • Monaco Asset Management left its Pliant Therapeutics share count unchanged in Q1 2026.
  • Pliant Therapeutics made up 0.45% of Monaco Asset Management's portfolio in Q1 2026, its #37 holding.
  • Monaco Asset Management first reported a position in Pliant Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Monaco Asset Management's 13F filing for Q1 2026, filed 11 May 2026.